What is the most important principle for tracking a stack?

Put everything on one timeline. The single biggest failure mode is fragmentation - doses in one place, labs in another, inventory in your head. When every compound, every injection, and every lab value share one dated timeline, a blood result is automatically read against what you were taking (and how far into a phase you were) when it was drawn, which is the only way multi-compound data becomes interpretable rather than a pile of disconnected numbers.

How do you keep track of bloodwork on a multi-compound protocol?

Draw labs at consistent times relative to your injections, record them on the same timeline as your doses, and note the context (phase, weight, recent changes). Because multiple compounds can push the same marker - for example testosterone raising hematocrit while a GLP-1 shifts lipids and HbA1c - you need to see which compounds were active when a value moved. Trend over time beats isolated snapshots, and timing relative to the last dose matters for hormone levels especially.

Practice guide · How to track a stack

Tracking a multi-compound protocol

Q: Why is tracking multiple compounds so hard?

Because each compound runs on a different clock and they all land on the same body. A testosterone ester might be every three or four days, a GLP-1 weekly, a peptide daily or five-on-two-off - so a single calendar of injections gets dense fast. On top of that, several compounds affect the same lab markers, inventory is spread across multiple vials at different fill levels, and the same dose means different things depending on which phase of a cycle you are in. Spreadsheets and notes apps fail because they were not built to hold schedule, labs, inventory, and phase context together.

Q: Can one app track TRT, GLP-1, and peptides together?

Yes - that is precisely what OptiPin is built for. It handles different schedules per compound (daily, every-few-days, weekly, cycled), forecasts blood levels for the compounds it models, keeps per-vial inventory with runout warnings, tags cycle phases so off-week dips are not misread, and puts labs and doses on one timeline. The design goal is that adding a fourth or fifth compound does not multiply the mental overhead.

One compound is a notes app. Three to five, TRT plus an AI, a GLP-1, a healing peptide, a GH secretagogue, running on different schedules and landing on the same labs, is where spreadsheets quietly fall apart. This is the practice guide: why multi-compound tracking is hard, and the principles that keep it legible. It's about method, not molecules, and it contains no doses or protocols.

By OptiPin Editorial·Last updated July 2026

The failure mode

Fragmentation

The fix

One timeline

Hardest part

Overlapping labs

Read doses in

Phase context

TL;DR

• Different clocks, one body. Daily, every-few-days, weekly, and cycled schedules collide fast on a single calendar.
• Fragmentation is the enemy. Doses, labs, and inventory in three places means none of them are interpretable.
• One timeline fixes it. Every compound, dose, and lab dated together, so a result reads against what was active.
• Overlapping labs are the trap. Several compounds move the same markers; you need to see which were on.
• Phase context matters. The same dose means different things depending on where you are in a cycle.

Why multi-compound tracking breaks the usual tools

A single compound is easy: one schedule, a handful of notes. The difficulty scales non-linearly because a real stack combines things that do not share a rhythm and do not stay in their lanes. Four problems compound at once:

• Different clocks. A testosterone ester every 3-4 days, a GLP-1 weekly, BPC-157 daily, a GH peptide five-on/two-off, on one calendar this becomes a dense, error-prone grid where a missed or doubled dose is easy.
• Overlapping labs. Testosterone moves hematocrit and E2; a GLP-1 moves HbA1c, lipids, and heart rate; a GH secretagogue moves IGF-1. Several compounds push the same panel, so a moved marker is ambiguous unless you know what was active.
• Inventory sprawl. Multiple vials at different fill levels and expiry dates; running out of one compound mid-protocol is a common, avoidable disruption.
• Phase context. The same dose during a blast, a cruise, or an off week means something different, and an off-week dip read without that context looks like the compound failing.

Spreadsheets and notes apps fail not because people are careless but because those tools hold one of these dimensions at a time, never all four together.

The principles that keep it legible

1. One timeline, no exceptions

The single highest-leverage habit is refusing to fragment. Every compound, every injection, and every lab value belongs on one dated timeline. The payoff is automatic context: a blood result is always read against which compounds were active, at what point in a phase, when it was drawn. Fragmented data, doses here, labs there, inventory in your head, is not just inconvenient, it is uninterpretable, because the connections that make the numbers mean anything are exactly what fragmentation destroys.

2. Per-compound schedules, not one calendar

Each compound needs its own schedule logic, daily, every-N-days, weekly, cycled, with its own reminders, rolled up into a single day view. That way "what do I take today" is answered without you mentally reconstructing five separate cadences.

3. Labs read in context, trended over time

Because markers overlap, isolated snapshots mislead. Draw labs at consistent times relative to your injections, record them on the shared timeline, and look at trends. When a value moves, the timeline shows which compounds were on and how far into a phase you were, turning "why is my hematocrit up?" from a guess into a readable answer.

4. Inventory as part of the protocol

Track each vial's remaining amount and expiry so a runout is predicted, not discovered. On a multi-vial stack this is the difference between a smooth protocol and an improvised gap.

5. Phase tagging

Tag the windows, on, off, blast, cruise, titration, so every data point is read against the phase it happened in. This is the same logic as the cycle-structure guide: phases exist so your data means something.

What good tracking actually prevents

Common failure	What one-timeline tracking does instead
"Which one caused this?" side-effect confusion	Side effect lines up against the compound/step that preceded it
A lab misread out of context	Value shown with active compounds + phase + timing
Running out of a vial mid-protocol	Runout predicted with a reorder warning
Off-week dip misread as failure	Phase tag makes the dip expected, not alarming

This is the problem OptiPin was built for

Everything above is a description of a design brief, and it is OptiPin's. It handles per-compound schedules (daily, every-few-days, weekly, cycled), forecasts blood levels for the compounds it models, keeps per-vial inventory with runout warnings, tags cycle phases so off-week dips are not misread, and puts labs and doses on one timeline, with insight summaries that connect dosing, symptoms, and bloodwork. The explicit design goal is that adding a fourth or fifth compound does not multiply the overhead, which is exactly where spreadsheets give up. Concrete stacks this applies to include the BPC-157 + TB-500 recovery stack and the retatrutide + TRT recomposition combination.

The honest part

This is a guide to tracking, not to what to run. It contains no doses or protocols, and good record-keeping is a harm-reduction step, not a substitute for medical supervision. Running multiple active compounds multiplies interactions, side-effect sources, and monitoring needs; several of the compounds people stack are unapproved or investigational, and some (like TRT) are prescription therapies that require a clinician. Track well and bring the data to a professional, don't let a tidy log substitute for one.

Add the fifth compound without the fifth spreadsheet

OptiPin holds every compound, schedule, vial, lab, and phase on one on-device timeline, and forecasts levels for the ones it models, so a complex stack stays legible instead of scattered. iOS, no account.

Download OptiPin

Frequently asked questions

Why is tracking multiple compounds so hard?

Each compound runs on a different clock (daily, every-few-days, weekly, cycled) and they all hit the same body: overlapping labs, inventory across many vials, and dose meaning that changes by phase. Spreadsheets and notes apps hold one of those dimensions at a time, not all together.

What's the most important principle?

One timeline. Fragmentation - doses, labs, and inventory in separate places - is the main failure mode. When everything shares one dated timeline, a lab result is automatically read against what you were taking and how far into a phase you were.

How do you track bloodwork on a stack?

Draw labs at consistent times relative to injections, record them on the same timeline as doses, note the context, and read trends not snapshots. Because multiple compounds move the same markers, you need to see which were active when a value changed.

Can one app track TRT, GLP-1, and peptides together?

Yes - that's what OptiPin is built for: per-compound schedules, level forecasting, per-vial inventory with runout warnings, cycle-phase tagging, and labs plus doses on one timeline, so a fourth or fifth compound doesn't multiply the overhead.

BPC-157 + TB-500 stack · Retatrutide + TRT stack · Cycle structure & tracking · Bloodwork to monitor · Feature guide · Peptides guide